BCDA
BioCardia, Inc.NASDAQHealthcare$1.20+3.45%ClosedMarket Cap: $7.0M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
14.18
P/S
0.00
EV/EBITDA
-0.61
DCF Value
$0.21
FCF Yield
-108.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-28372.4%
ROA
-241.1%
ROIC
-581.7%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | -Infinity% | $-2.0M | $-2.0M | $-0.18 | — |
| FY 2025 | $0.00 | -Infinity% | $-8.3M | $-8.2M | $-1.23 | — |
| Q3 2025 | $0.00 | -Infinity% | $-1.5M | $-1.5M | $-0.24 | — |
| Q2 2025 | $0.00 | -Infinity% | $-2.1M | $-2.0M | $-0.40 | — |
| Q1 2025 | $0.00 | -Infinity% | $-2.7M | $-2.7M | $-0.99 | — |
| Q4 2024 | $0.00 | -Infinity% | $-2.3M | $-2.3M | $-0.50 | — |
| FY 2024 | $58.0K | -7463.8% | $-8.0M | $-7.9M | $-2.90 | — |
| Q3 2024 | $0.00 | -Infinity% | $-1.8M | $-1.7M | $-0.61 | — |
| Q2 2024 | $3.0K | -26566.7% | $-1.6M | $-1.6M | $-0.88 | — |
| Q1 2024 | $55.0K | -2156.4% | $-2.3M | $-2.3M | $-1.35 | — |
| Q4 2023 | $13.0K | -8792.3% | $-2.1M | $-2.1M | $-1.38 | — |
| FY 2023 | $477.0K | -1519.7% | $-11.6M | $-11.6M | $-8.19 | — |